文献速递糖尿病

专科治疗住院患者:外科糖尿病管理(STOIC-D Surgery)试验:电子专科主导糖尿病照护模式早期干预的随机对照试验

The Specialist Treatment of Inpatients: Caring for Diabetes in Surgery (STOIC-D Surgery) Trial: A Randomized Controlled Trial of Early Intervention With an Electronic Specialist-Led Model of Diabetes Care.
PubMed 文献 · Diabetes Care · 2024-01-01

在皇家墨尔本医院开展随机对照试验,纳入外科病房已知糖尿病或新发现高血糖的成年住院患者1371例,按1:1随机分为早期干预组(680例)和标准糖尿病照护组(691例)。早期干预组中位患者日平均血糖为8.2 mmol/L,低于对照组的8.6 mmol/L,估计差值为-0.3 mmol/L(95% CI -0.4至-0.2,P<0.0001);医疗保健相关感染发生率干预组为77例(11%),对照组为110例(16%),绝对风险差为-4.6%(95% CI -8.2至-1.0,P=0.016)。

要点

  • 早期干预组中位患者日平均血糖8.2 mmol/L,低于标准照护组的8.6 mmol/L。
  • 医疗保健相关感染干预组77例(11%),低于标准照护组的110例(16%)。
  • 在外科住院患者中,电子专科主导的早期糖尿病管理可降低血糖和医疗保健相关感染。

核心结论

  • 在外科住院患者中,电子专科主导的糖尿病照护模式早期干预可降低血糖和医疗保健相关感染。

研究设计与样本

  • 研究为随机对照试验,在皇家墨尔本医院开展,纳入研究期间入住外科病房的已知糖尿病或新发现高血糖(至少一次随机血糖≥11.1 mmol/L)的成年患者。
  • 2021年2月12日至2021年12月17日期间,1371例入院患者符合纳入标准,680例分配至早期干预组,691例分配至标准糖尿病照护组,按1:1随机分组,两组基线特征相似。
  • 干预措施为专科住院糖尿病团队使用电子工具进行患者识别、建议沟通和治疗强化,实现早期会诊。

主要发现

  • 早期干预组中位患者日平均血糖为8.2 mmol/L(四分位距6.9-10.0 mmol/L),标准照护组为8.6 mmol/L(四分位距7.2-10.3 mmol/L),估计差值为-0.3 mmol/L(95% CI -0.4至-0.2 mmol/L,P<0.0001)。
  • 医疗保健相关感染发生率早期干预组为77例(11%),标准照护组为110例(16%),绝对风险差为-4.6%(95% CI -8.2至-1.0,P=0.016)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the effect of early intervention with an electronic specialist-led "proactive" model of care on glycemic and clinical outcomes. RESEARCH DESIGN AND METHODS: The Specialist Treatment of Inpatients: Caring for Diabetes in Surgery (STOIC-D Surgery) randomized controlled trial was performed at the Royal Melbourne Hospital. Eligible participants were adults admitted to a surgical ward during the study with either known diabetes or newly detected hyperglycemia (at least one random blood glucose result ≥11.1 mmol/L). Participants were randomized 1:1 to standard diabetes care or the intervention consisting of an early consult by a specialist inpatient diabetes team using electronic tools for patient identification, communication of recommendations, and therapy intensification. The primary outcome was median patient-day mean glucose (PDMG). The key secondary outcome was incidence of health care-associated infection (HAI). RESULTS: Between 12 February 2021 and 17 December 2021, 1,371 admissions met inclusion criteria, with 680 assigned to early intervention and 691 to standard diabetes care. Baseline characteristics were similar between groups. The early intervention group achieved a lower median PDMG of 8.2 mmol/L (interquartile range [IQR] 6.9-10.0 mmol/L) compared with 8.6 mmol/L (IQR 7.2-10.3 mmol/L) in the control group for an estimated difference of -0.3 mmol/L (95% CI -0.4 to -0.2 mmol/L, P < 0.0001). The incidence of HAI was lower in the intervention group (77 [11%] vs. 110 [16%]), for an absolute risk difference of -4.6% (95% CI -8.2 to -1.0, P = 0.016). CONCLUSIONS: In surgical inpatients, early diabetes management intervention with an electronic specialist-led diabetes model of care reduces glucose and HAI.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Barmanray RD, Kyi M, Colman PG, et al. The Specialist Treatment of Inpatients: Caring for Diabetes in Surgery (STOIC-D Surgery) Trial: A Randomized Controlled Trial of Early Intervention With an Electronic Specialist-Led Model of Diabetes Care. Diabetes Care. 2024. PMID: 38237121. doi:10.2337/dc23-1905

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。